HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jonathan French Selected Research
Jonathan French Research Topics
Disease
3
Breast Neoplasms (Breast Cancer)
01/2019 - 12/2017
2
Systemic Lupus Erythematosus (Libman-Sacks Disease)
12/2023 - 01/2023
2
Infections
11/2022 - 12/2015
2
Rheumatoid Arthritis
12/2015 - 06/2010
2
Disease Progression
03/2011 - 01/2010
1
Reinfection
01/2023
1
Malaria
01/2023
1
Pelvic Pain
01/2022
1
Stomach Neoplasms (Stomach Cancer)
01/2022
1
Peritoneal Neoplasms
01/2022
1
Pain (Aches)
01/2022
1
Neoplasms (Cancer)
01/2022
1
Endometriosis
01/2022
1
Giant Cell Tumor of Tendon Sheath
11/2021
1
Body Weight (Weight, Body)
10/2016
1
Toxemia
10/2016
1
Anthrax
10/2016
1
Uterine Hemorrhage (Uterine Bleeding)
03/2003
Drug/Important Bio-Agent (IBA)
3
Ado-Trastuzumab Emtansine
IBA
01/2019 - 12/2017
2
Anti-Bacterial Agents (Antibiotics)
IBA
11/2022 - 10/2016
2
human ERBB2 protein
IBA
01/2019 - 12/2017
2
tofacitinib
IBA
12/2015 - 06/2010
2
Antirheumatic Agents (DMARD)
IBA
12/2015 - 06/2010
1
Prostaglandins A
IBA
01/2023
1
2- methyl- 3- (4- phenylpiperidino)propionohydroxamic acid hydrochloride (K 76)
IBA
01/2023
1
artemisinin (artemisinine)
IBA
01/2023
1
Lumefantrine Drug Combination Artemether (Coartem)
FDA Link
01/2023
1
Estradiol (Delestrogen)
FDA Link
Generic
01/2022
1
linzagolix
IBA
01/2022
1
Transferases
IBA
01/2022
1
avelumab
IBA
01/2022
1
LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)
IBA
01/2022
1
Albumins
IBA
01/2022
1
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
01/2022
1
C-Reactive Protein
IBA
01/2022
1
pexidartinib
IBA
11/2021
1
pertuzumab
IBA
01/2019
1
ErbB Receptors (EGF Receptor)
IBA
12/2017
1
taxane
IBA
12/2017
1
Lapatinib (GW572016)
FDA Link
12/2017
1
Capecitabine (Xeloda)
FDA Link
12/2017
1
Trastuzumab (Herceptin)
FDA Link
12/2017
1
obiltoxaximab
IBA
10/2016
1
anthrax toxin (anthrax lethal factor)
IBA
10/2016
1
Antitoxins
IBA
10/2016
1
Monoclonal Antibodies
IBA
10/2016
1
Adalimumab (Humira)
FDA Link
12/2015
1
Janus Kinase Inhibitors
IBA
12/2015
1
Apolipoproteins E (ApoE)
IBA
03/2011
1
Janus Kinases
IBA
06/2010
1
Acetylcholinesterase
IBA
01/2010
Therapy/Procedure
3
Therapeutics
12/2023 - 12/2017
1
Drug Therapy (Chemotherapy)
01/2022
1
Induction Chemotherapy
01/2022
1
Contraception (Birth Control)
03/2003